Enzalutamide in Prostate Cancer after Chemotherapy

被引：5
|
作者：
Berruti, Alfredo [1 ]
Generali, Daniele [2 ]
Tampellini, Marco [3 ]
机构：
[1] Univ Brescia, Brescia, Italy
[2] Istituti Ospitalieri, Cremona, Italy
[3] Univ Turin, Orbassano, Italy
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2012年 / 367卷 / 25期
关键词：
INCREASED SURVIVAL; MIGRAINE;
D O I：
10.1056/NEJMc1212940
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2448 / 2448
页数：1
相关论文
共 50 条
  • [41] The evolving role of enzalutamide on the treatment of prostate cancer
    Nadal, Rosa
    Bellmunt, Joaquim
    FUTURE ONCOLOGY, 2016, 12 (05) : 607 - 616
  • [42] Enzalutamide as a Radiosensitizer in Prostate Cancer Cell Lines
    Barrado, M.
    Escors, D.
    Arias, F.
    Blanco, I.
    Arteta, V.
    Visus, I.
    Campo, M.
    Flamarique, S.
    Navarrete, P. A.
    Martinez, E.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02): : E212 - E212
  • [43] Molecular mechanisms of enzalutamide resistance in prostate cancer
    Blatt, Eliot B.
    Raj, Ganesh, V
    CANCER DRUG RESISTANCE, 2019, 2 (02) : 189 - 197
  • [44] PROSTATE CANCER Fitting to overcome enzalutamide resistance
    Thoma, Clemens
    NATURE REVIEWS UROLOGY, 2016, 13 (10) : 564 - +
  • [45] Enzalutamide: A Review of Its Use in Chemotherapy-Naive Metastatic Castration-Resistant Prostate Cancer
    Keating, Gillian M.
    DRUGS & AGING, 2015, 32 (03) : 243 - 249
  • [46] Enzalutamide in Castration-resistant Prostate Cancer Patients Progressing After Docetaxel and Abiraterone
    Schrader, Andres Jan
    Boegemann, Martin
    Ohlmann, Carsten-H.
    Schnoeller, Thomas J.
    Krabbe, Laura-Maria
    Hajili, Turkan
    Jentzmik, Florian
    Stoeckle, Michael
    Schrader, Mark
    Herrmann, Edwin
    Cronauer, Marcus V.
    EUROPEAN UROLOGY, 2014, 65 (01) : 30 - 36
  • [47] Enzalutamide After Docetaxel and Abiraterone Therapy in Metastatic Castration-Resistant Prostate Cancer
    Schmid, Sebastian Christoph
    Geith, Alexander
    Boeker, Alena
    Tauber, Robert
    Seitz, Anna Katharina
    Kuczyk, Markus
    von Klot, Christoph
    Gschwend, Juergen Erich
    Merseburger, Axel Stuart
    Retz, Margitta
    ADVANCES IN THERAPY, 2014, 31 (02) : 234 - 241
  • [48] Enzalutamide after failure of docetaxel and abiraterone in metastatic castrate-resistant prostate cancer
    Thomson, David
    Charnley, Natalie
    Parikh, Omi
    EUROPEAN JOURNAL OF CANCER, 2014, 50 (05) : 1040 - 1041
  • [49] The EMBARK trial: The use of enzalutamide in biochemically recurrent prostate cancer after primary therapy
    Shelan, Mohamed
    Mathier, Etienne
    Aebersold, Daniel M.
    Wiegel, Thomas
    STRAHLENTHERAPIE UND ONKOLOGIE, 2025,
  • [50] Sequencing in metastatic castrate-resistant prostate cancer with enzalutamide in a post-chemotherapy setting.
    Feinberg, Bruce A.
    Pandya, Bhavik
    Radtchenko, Janna
    Garofalo, David
    Flanders, Scott
    Brown, Bruce
    Barlev, Arie
    Bhor, Menaka
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
12345